|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/67 | |
| C12N 15/85 | |||
| A61K 39/12 |
| (11) | Number of the document | 3230458 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15817068.8 |
| Date of filing the European patent application | 2015-12-11 | |
| (97) | Date of publication of the European application | 2017-10-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/002501 |
| Date | 2015-12-11 |
| (87) | Number | WO 2016/091391 |
| Date | 2016-06-16 |
| (30) | Number | Date | Country code |
| PCT/EP2014/0033 | 2014-12-12 | WO |
| (72) |
THE , Andreas, DE
SCHLAKE, Thomas, DE
GRUND, Stefanie, DE
|
| (73) |
CureVac AG,
Paul-Ehrlich-Str. 15, 72076 Tübingen,
DE
|
| (54) | ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION |
| ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION |